Published by Coherent Market Insights
Posted on September 22, 2021
Coherent Market Insights recently published an in depth study of Antiparasitic Drugs Market covering interesting aspects of the market with supporting development scenarios starting from 2021-2027. The report delivers the clean elaborated structure of the Market comprising each and each business-related information of the market at a worldwide level. the entire range of data associated with the worldwide Market is obtained through various sources and this obtained bulk of the knowledge is arranged, processed, and represented by a gaggle of specialists through the appliance of various methodological techniques and analytical tools like SWOT analysis to get an entire set of trade-based study regarding the Antiparasitic Drugs.
Request PDF With Detailed Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/3782
This report assesses the growth rate and the market value on the basis of the key market dynamics, as well as the growth inducing factors. The complete study is based on the up-to-date industry news, growth potentials, and Market trends. It also contains an in-depth analysis of the market and competitive scenario, together with the analysis of the leading competitors.
Antiparasitic drugs are a category of medicines that are mainly indicated for the cure of allergic parasitic infections, like those caused by the amoeba, helminth, parasitic protozoans, and other fungi, among many others. Medicine in this category is called antifungal and it contains active ingredients capable of preventing the growth of such microorganisms. Many drug manufacturers are focused on launching generic drug products, so as to expand their market presence. A generic drug contains the same chemical substance as a drug that was original protected by chemical patients. These drugs are allowed to sell after the patents on the original drugs expire. Since there is an increasing launch of generic drugs, the antiparasitic drugs market could expand in the near future. Recently, in May 2021, Bajaj Healthcare launched Ivejaj, an antiparasitic drug, for the treatment of COVID-19.
Since the prevalence of parasitic diseases such as Chagas disease has increased, the demand for antiparasitic drugs is rapidly increasing. As per the Pan American Health Organization (PAHO), around 30,000 new cases and 12,000 deaths due to Chagas disease are reported annually across the Americas. As per the same source, around 8,000 newborns become infected during digestion. Chagas disease can be treated with Benznidazole and also Nifurtimox. Hence such factors can boost growth of the antiparasitic drugs market.
Some common categories of antifungal drugs include the streptomycin family, vancomycin, lincosidic acid, systemic enzymes, etc. These drugs are available in tablet forms and oral solutions. Some of them also contain components capable of reducing the activity of some microorganisms responsible for food poisoning. Despite these advantageous factors, there are certain challenges that remain prevalent and can impede growth of the market. For instance, antiparasitic drugs have numerous adverse effects, which limit their demand. Besides, there are high possibilities of substance abuse and addiction that can inhibit growth of the antiparasitic drugs market.
Artemether is a drug that has strong antibacterial properties. Its action is similar to that of chlorhexidine but less toxic. The active ingredient is sulfonyl methane, which acts as a deodorizer and destroys microorganisms. As far as geographical impact is concerned, Africa seems to be gaining significant traction in the antiparasitic drugs market. This is typically due to the fact there is growing risk of malaria in the region. In fact, as per the World Health Organization (WHO), around 92% of malaria cases occur in sub-Saharan Africa. On the contrary, Asia Pacific is exhibiting a positive outlook due to increasing cases of parasitic infectious diseases.
Competitive Analysis:
The key players are highly focusing on innovation in production technologies to improve efficiency and shelf life. The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in optimal strategies. Few Market Key Players are Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, Roche Inc., Arbor Pharmaceuticals Inc., Sanofi, AstraZeneca plc., and Alkem Laboratories Limited
Order a Copy of This Market Report With Instant USD 2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/3782
Some Important TOC:
Market Overview
Global Market Landscape by Player
Players Profiles
Global Production, Revenue (Value), Price Trend by Type
Market Analysis by Application
Global Production, Consumption, Export, Import by Region (2013-2021)
Production, Revenue (Value) by Region (2013-2021)
Manufacturing Analysis
Industrial Chain, Sourcing Strategy and Downstream Buyers
Market Dynamics
Global Market Forecast (2021-2027)
Research Findings and Conclusion
Appendix
The following queries are answered in this comprehensive document:
1. What is the market size of the global and regional levels?
2. Which are the top countries and what is their market size?
3. Which are the growth opportunities in the coming years?
4. Which are the top players and what is their market share?
5. Which are the risk factors affecting market growth?
Thanks for reading this article, you can also get individual chapter wise section or region wise report versions like North America, Europe or Asia.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Antiparasitic Drugs Market CAGR of 5.2% By 2027 Technology Status, Current Trends, Key Challenges, Top Key Players and Recent Growth in Pharmaceuticals appeared first on Gatorledger.
Coherent Market Insights recently published an in depth study of Antiparasitic Drugs Market covering interesting aspects of the market with supporting development scenarios starting from 2021-2027. The report delivers the clean elaborated structure of the Market comprising each and each business-related information of the market at a worldwide level. the entire range of data associated with the worldwide Market is obtained through various sources and this obtained bulk of the knowledge is arranged, processed, and represented by a gaggle of specialists through the appliance of various methodological techniques and analytical tools like SWOT analysis to get an entire set of trade-based study regarding the Antiparasitic Drugs.
Request PDF With Detailed Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/3782
This report assesses the growth rate and the market value on the basis of the key market dynamics, as well as the growth inducing factors. The complete study is based on the up-to-date industry news, growth potentials, and Market trends. It also contains an in-depth analysis of the market and competitive scenario, together with the analysis of the leading competitors.
Antiparasitic drugs are a category of medicines that are mainly indicated for the cure of allergic parasitic infections, like those caused by the amoeba, helminth, parasitic protozoans, and other fungi, among many others. Medicine in this category is called antifungal and it contains active ingredients capable of preventing the growth of such microorganisms. Many drug manufacturers are focused on launching generic drug products, so as to expand their market presence. A generic drug contains the same chemical substance as a drug that was original protected by chemical patients. These drugs are allowed to sell after the patents on the original drugs expire. Since there is an increasing launch of generic drugs, the antiparasitic drugs market could expand in the near future. Recently, in May 2021, Bajaj Healthcare launched Ivejaj, an antiparasitic drug, for the treatment of COVID-19.
Since the prevalence of parasitic diseases such as Chagas disease has increased, the demand for antiparasitic drugs is rapidly increasing. As per the Pan American Health Organization (PAHO), around 30,000 new cases and 12,000 deaths due to Chagas disease are reported annually across the Americas. As per the same source, around 8,000 newborns become infected during digestion. Chagas disease can be treated with Benznidazole and also Nifurtimox. Hence such factors can boost growth of the antiparasitic drugs market.
Some common categories of antifungal drugs include the streptomycin family, vancomycin, lincosidic acid, systemic enzymes, etc. These drugs are available in tablet forms and oral solutions. Some of them also contain components capable of reducing the activity of some microorganisms responsible for food poisoning. Despite these advantageous factors, there are certain challenges that remain prevalent and can impede growth of the market. For instance, antiparasitic drugs have numerous adverse effects, which limit their demand. Besides, there are high possibilities of substance abuse and addiction that can inhibit growth of the antiparasitic drugs market.
Artemether is a drug that has strong antibacterial properties. Its action is similar to that of chlorhexidine but less toxic. The active ingredient is sulfonyl methane, which acts as a deodorizer and destroys microorganisms. As far as geographical impact is concerned, Africa seems to be gaining significant traction in the antiparasitic drugs market. This is typically due to the fact there is growing risk of malaria in the region. In fact, as per the World Health Organization (WHO), around 92% of malaria cases occur in sub-Saharan Africa. On the contrary, Asia Pacific is exhibiting a positive outlook due to increasing cases of parasitic infectious diseases.
Competitive Analysis:
The key players are highly focusing on innovation in production technologies to improve efficiency and shelf life. The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in optimal strategies. Few Market Key Players are Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, Roche Inc., Arbor Pharmaceuticals Inc., Sanofi, AstraZeneca plc., and Alkem Laboratories Limited
Order a Copy of This Market Report With Instant USD 2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/3782
Some Important TOC:
Market Overview
Global Market Landscape by Player
Players Profiles
Global Production, Revenue (Value), Price Trend by Type
Market Analysis by Application
Global Production, Consumption, Export, Import by Region (2013-2021)
Production, Revenue (Value) by Region (2013-2021)
Manufacturing Analysis
Industrial Chain, Sourcing Strategy and Downstream Buyers
Market Dynamics
Global Market Forecast (2021-2027)
Research Findings and Conclusion
Appendix
The following queries are answered in this comprehensive document:
1. What is the market size of the global and regional levels?
2. Which are the top countries and what is their market size?
3. Which are the growth opportunities in the coming years?
4. Which are the top players and what is their market share?
5. Which are the risk factors affecting market growth?
Thanks for reading this article, you can also get individual chapter wise section or region wise report versions like North America, Europe or Asia.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Antiparasitic Drugs Market CAGR of 5.2% By 2027 Technology Status, Current Trends, Key Challenges, Top Key Players and Recent Growth in Pharmaceuticals appeared first on Gatorledger.
Explore more articles in the Research Reports category
